Pneumocystis jirovecii pneumonia complicated a case of SARS‐CoV‐2 infection and multiple sclerosis after treatment with rituximab

Case Report: Pneumonia in a Patient With Combined Variable Immunodeficiency: COVID-19 or Pneumocystis Pneumonia?

(2022) Shabnam Tehrani et al.   Frontiers in Medicine

COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies

(2021) Anthony T. Reder et al.   CNS DRUGS

Pneumocystis pneumonia in the COVID-19 pandemic era: similarities and challenges

(2021) Magdalena Szydłowicz et al.   TRENDS IN PARASITOLOGY

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?

(2020) Jeffrey Laurence   AIDS PATIENT CARE AND STDS

A Case of COVID-19 and Pneumocystis jirovecii Co-infection

(2020) Aravind A. Menon et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models

(2019) Benjamin Segal   Journal of Clinical Medicine

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study

(2018) Alexander F A D Schauwvlieghe et al.   Lancet Respiratory Medicine

Rituximab in multiple sclerosis

(2016) Jonatan Salzer et al.   NEUROLOGY

Pneumocystis jiroveci pneumonia in patients with systemic lupus erythematosus after rituximab therapy

(2012) M-J Tsai et al.   LUPUS